An observational study analyzing impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes
Latest Information Update: 04 Apr 2022
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- 04 Apr 2022 New trial record
- 26 Mar 2022 Results published in the British Journal of Cancer